Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study of the Safety of Atezolizumab in Patients With Advanced or Metastatic Urothelial Carcinoma in Argentina

NCT03330886 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT03330886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03330886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study of the Safety of Atezolizumab in Patients With Advanced or Metastatic Urothelial Carcinoma in Argentina
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
February 9, 2018
Completion date
March 2, 2019
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

urothelial carcinoma